Number of ongoing Clinical Trials (for drugs) involving Recurrent Medulloblastoma by Phase

Industry: Pharmaceuticals
Current: Other Industry Indicators

There are currently 47 ongoing clinical trials involving Recurrent Medulloblastoma
Of the 47 trials,24 trials are in Phase II
Furthermore, 10 trials are in Phase I

Number of ongoing Clinical Trials (for drugs) involving Recurrent Medulloblastoma by Phase

Related Data & Insights

Number of ongoing Clinical Trials (for drugs) involving Mantle Cell Lymphoma by Phase

Global Spain Pharmaceuticals Oncology Therapy Area

Number of ongoing Clinical Trials (for drugs) involving Low-Grade Glioma by Phase

Global Spain Pharmaceuticals Oncology Therapy Area

Number of ongoing Clinical Trials (for drugs) involving Gastrointestinal Stromal Tumor (GIST) by Phase

Global Spain Pharmaceuticals Oncology Therapy Area

Number of ongoing Clinical Trials (for drugs) involving Angiosarcoma Of Breast by Phase

Global Spain Pharmaceuticals Oncology Therapy Area

Number of ongoing Clinical Trials (for drugs) involving Hereditary Nonpolyposis Colon Cancer by Phase

Global Spain Pharmaceuticals Oncology Therapy Area

Number of ongoing Clinical Trials (for drugs) involving Carcinoma of Unknown Primary (Occult Primary Tumor/Cancer of Unknown Primary) by Phase

Global Spain Pharmaceuticals Oncology Therapy Area

Related Companies

Johnson & Johnson

United States of America

Sinopharm Group Co Ltd

China

HCA Healthcare Inc

United States of America

Eli Lilly and Co

United States of America

Merck & Co Inc

United States of America

Pfizer Inc

United States of America

AbbVie Inc

United States of America

AstraZeneca Plc

United Kingdom

Novartis AG

Switzerland

Sanofi

France

Still looking?

Don’t wait - discover a universe of connected data & insights with your next search. Browse over 28M data points across 22 industries.

Explorer

Access more premium companies when you subscribe to Explorer